Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,082 | -32,864 | -20,771 | -11,025 | -30,008 |
| Depreciation Amortization | 79 | 73 | 58 | 34 | 224 |
| Other Working Capital | 1,037 | 4,595 | 1,222 | 1,736 | 10,436 |
| Other Operating Activity | 7,605 | 5,848 | 4,129 | 1,779 | 7,368 |
| Operating Cash Flow | $-33,361 | $-22,348 | $-15,362 | $-7,476 | $-11,980 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10,000 | -7,500 | -5,000 | -2,500 | -5,000 |
| Common Stock Issued | 28,211 | 27,789 | 15,497 | N/A | 775 |
| Financing Cash Flow | $18,211 | $20,289 | $10,497 | $-2,500 | $-4,225 |
| Exchange Rate Effect | 224 | -237 | 86 | 130 | -100 |
| Beginning Cash Position | 35,848 | 35,848 | 35,848 | 35,848 | 52,153 |
| End Cash Position | 20,922 | 33,552 | 31,069 | 26,002 | 35,848 |
| Net Cash Flow | $-14,926 | $-2,296 | $-4,779 | $-9,846 | $-16,305 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,361 | -22,348 | -15,362 | -7,476 | -11,980 |
| Free Cash Flow | -33,361 | -22,348 | -15,362 | -7,476 | -11,980 |